Archive for September, 2003
GlaxoSmithKline Reveals Ingenuity
GlaxoSmithKline Reveals Ingenuity
In a further validation of Big Pharma�s acceptance of systems biology, GlaxoSmithKline has licensed part of the Ingenuity Pathways Knowledge Base to facilitate genome-wide computational analysis of biological systems underlying disease.
The Best in Drugs and Biotech
The Best in Drugs and Biotech: “S&P’s Herman Saftlas and Frank DiLorenzo share some favorites in these resurgent sectors, including Barr Pharmaceuticals and MedImmune “
What VCs Don’t Tell You
What VCs Don’t Tell You: “To secure funding, an entrepreneur needs to appreciate the goals and strategies at work on the other side the table. Here’s a guide “
Building a Better R&D Mousetrap
Building a Better R&D Mousetrap: “By posting their scientific conundrums online, companies like Eli Lilly and Procter & Gamble have discovered a rich new source of brainpower.”
A WTO deal on drugs
A WTO deal on drugs
India and Brazil are good at making cheap copies of life-saving drugs. Now they are allowed to export them too…
